The Kenneth Rainin Foundation has awarded $4.15 million through our Innovator Awards Program.
As a preeminent clinician-scientist studying the molecular mechanisms underlying inflammation and cancer, Dr. Averil Ma’s expertise has guided our focus on IBD research.
The Kenneth Rainin Foundation is pleased to announce that Scott Snapper, MD, PhD, is the new Co-Chair of our Scientific Advisory Board, joining fellow Co-Chair Bana Jabri, MD, PhD.
We are thrilled to welcome scientists and other colleagues back in person to the Foundation’s annual Innovations Symposium on July 17-18 in San Francisco.
The G-Tech Medical team discusses the impact of early funding on their “EKG for the gut,” exciting data emerging from current studies and growing interest from researchers and industry.
Our Health grantmaking aims to advance game-changing research that has the potential to improve the lives of people with IBD so it’s thrilling when our grantees gain recognition or high-profile journals publish their findings.
We welcomed students, academic and industry researchers, clinicians, funders and editors of science and health journals to our 2022 virtual Innovations Symposium.
Grantees are testing novel ideas from bright light therapy to diet and the gut-brain connection in the hopes of discovering new ways to reduce the risk of flare-ups and improve the lives of patients with IBD.
The Foundation’s Scientific Advisory Board is a dynamic mix of leading researchers and key strategic partners who provide essential guidance and scientific expertise to our Health Program.
Two of our grantees illustrate distinct and shared ways that the pandemic has disrupted biomedical research and affected the scientific community.
